Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

The introduction of vaccination programs against measles, mumps, and rubella (MMR) led to significant global reduction in morbidity and mortality from these diseases. The currently recommended MMR vaccination schedule in the United States of America comprises 2 vaccine doses typically administered a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Elyazeed, Remon, Jennings, William, Severance, Randall, Noss, Michael, Caplanusi, Adrian, Povey, Michael, Henry, Ouzama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314414/
https://www.ncbi.nlm.nih.gov/pubmed/29902133
http://dx.doi.org/10.1080/21645515.2018.1489186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314414/
https://www.ncbi.nlm.nih.gov/pubmed/29902133
http://dx.doi.org/10.1080/21645515.2018.1489186

Ejemplares similares